Navigation Links
Small bowel blood flow in healthy subjects receiving low-dose aspirin
Date:1/25/2011

Low-dose acetylsalicylic acid (ASA) has been widely used for prevention of cardiovascular and cerebrovascular events. Several studies have shown that mucosal breaks caused by taking low-dose ASA occurred not only in the upper gastrointestinal tract but also in the lower gastrointestinal tract. However the cause of small bowel injury is not clear. One of the mechanisms of drug-induced small bowel damage is decrease in blood flow.

A research article to be published on January 14, 2011 in the World Journal of Gastroenterology addresses this question. The authors investigated the relationship between low-dose ASA-induced small bowel mucosal damage and small bowel blood flow, and also evaluated the preventive effect of rebamipide against small bowel damage and the effect of rebamipide on blood flow.

The results indicated that low-dose ASA-induced decrease in small bowel blood flow is correlated with small-bowel mucosal injury. Rebamipide does not decrease small bowel blood flow.

This study may represent a future strategy for therapeutic intervention in the treatment of patients with low-dose aspirin-induced small bowel mucosal damage.


'/>"/>

Contact: Ye-Ru Wang
wjg@wjgnet.com
86-105-908-0039
World Journal of Gastroenterology
Source:Eurekalert

Page: 1

Related medicine news :

1. Heavy Smoking Linked to Small Increase in Breast Cancer Risk
2. Preparing Small Doses of Medication From Syringes Called Risky
3. Small Spreads of Breast Cancer May Not Affect Survival
4. Small molecules may prevent ebola infection
5. MIT neuroscientists explain Proustian effect of small details attached to big memories
6. Deadliest Cancer Getting Smaller Chunk of Research Dollars
7. Small molecule may disarm enemy of cancer-fighting p53
8. Small assist device used in emergency case as twin, heart booster pumps for first time in US
9. Unexpectedly small effects of mutations in bacteria bring new perspectives
10. UCI non-small cell lung cancer study highlights advances in targeted drug therapy
11. Small particles show big promise in beating unpleasant odors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... ... December 02, 2016 , ... Metabolic Code (MC) ... nutraceuticals and help doctors more efficiently manage their practice. Power2Practice is adding ... platform for Integrative and Functional Medicine. , The Metabolic Code platform provides ...
(Date:12/4/2016)... ... , ... While James Earl Jones is known for myriad roles on stage ... "Front Page". One of the forthcoming episodes examines mammogram techniques; a very important part ... part due to early detection. Like any other disease, treatments have a much higher ...
(Date:12/4/2016)... California (PRWEB) , ... December 04, 2016 , ... ... third presets that have new attractive animation styles with unique displacement design elements," ... features 30 pre-animated lower third designs. Choose from a variety of design styles ...
(Date:12/4/2016)... ... , ... Responsible dental care hinges on regular brushing of the teeth. However, ... important necessity inspired an inventor from Las Vegas, Nev., to design the BRUSH PROPER. ... or avoid bad techniques of brushing the teeth in order to prevent cavities," he ...
(Date:12/2/2016)... ... December 02, 2016 , ... Two years ... heroin that was watched live by 1 million viewers and won numerous honors, ... , ASU students at the Walter Cronkite School of Journalism and Mass Communication ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... Israel , December 5, 2016 ... identifying, in-licensing and developing promising therapeutic candidates, presents positive Phase ... BL-8040, the Company,s leading oncology platform at the ongoing 58th ... San Diego, California . ... , , ...
(Date:12/5/2016)... Taiwan , Dec. 5, 2016 ... non-inferiority to hydroxyurea (HU) in Complete Hematologic Response (CHR) ... profile of ropeginterferon alfa-2b versus HU AOP ... follow-up trial CONTINUATION-PV to obtain European marketing authorization in the ... data to the FDA as it seeks approval for commercialization ...
(Date:12/4/2016)... --  Pairnomix, LLC, a genetic research company and member ... White House, today announced that findings from its first case ... therapies for a patient with epileptic encephalopathy caused by a ... the 70 th Annual Meeting of the American ... December 2-6, 2016.  Pairnomix, unique process involves creating ...
Breaking Medicine Technology: